PUMA mediates the apoptotic response to p53 in colorectal cancer cells

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2003-02-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.2627984100PMID 12574499PMCID PMC149936
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 and apoptosis.

  2007cited by this paper
• BH3 - only proteins: evolutionarily conserved proapoptotic Bcl - 2 family members essential for init

  2002cited by this paper
• Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics.

  2002cited by this paper
• The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

  2002cited by this paper
• And all of a sudden it's over: mitochondrial outer-membrane permeabilization in apoptosis.

  2002cited by this paper
• The Bcl2 family: regulators of the cellular life-or-death switch

  2002cited by this paper
• Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.

  2002cited by this paper
• Dissecting p53 tumor suppressor functions in vivo.

  2002cited by this paper
• Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage

  2002cited by this paper
• BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis.

  2001cited by this paper
• PUMA induces the rapid apoptosis of colorectal cancer cells.

  2001cited by this paper
• BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak.

  2001cited by this paper
• PUMA, a novel proapoptotic gene, is induced by p53.

  2001cited by this paper
• Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo

  2001cited by this paper
• The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress.

  2001cited by this paper
• Securin is required for chromosomal stability in human cells.

  2001cited by this paper
• Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals

  2001cited by this paper
• The expanding role of mitochondria in apoptosis.

  2001cited by this paper
• p53: death star.

  2000cited by this paper
• Role of BAX in the apoptotic response to anticancer agents.

  2000cited by this paper
• Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution.

  2000cited by this paper
• Changes in p21WAF1, pRb, Mdm-2, Bax and Bcl-2 expression in cervical cancer cell lines transfected with a p53 expressing adenovirus.

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• Cooperative effects of genes controlling the G(2)/M checkpoint.

  2000cited by this paper
• Identification and classification of p53-regulated genes.

  1999cited by this paper
• Regulation of the p53 Tumor Suppressor Protein*

  1999cited by this paper
• New approaches to understanding p53 gene tumor mutation spectra.

  1999cited by this paper
• Adenovirus-mediated transfer of wild-type p53 gene results in apoptosis or growth arrest in human cultured gastric carcinoma cells.

  1999cited by this paper
• BCL-2 family members and the mitochondria in apoptosis.

  1999cited by this paper
• p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.

  1999cited by this paper
• The p53 pathway

  1999cited by this paper
• A new p21waf1/cip1 isoform is an early event of cell response to oxidative stress

  1998cited by this paper
• Regulation of p53 downstream genes.

  1998cited by this paper
• Phenotypic alterations of small cell lung carcinoma induced by different levels of wild-type p53 expression

  1998cited by this paper
• Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

  1998cited by this paper
• The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression.

  1998cited by this paper
• A simplified system for generating recombinant adenoviruses.

  1998cited by this paper
• Radiation-induced apoptosis is not enhanced by expression of either p53 or BAX in SW626 ovarian cancer cells

  1997cited by this paper
• Somatic Frameshift Mutations in the BAX Gene in Colon Cancers of the Microsatellite Mutator Phenotype

  1997cited by this paper
• bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis.

  1997cited by this paper
• Bax suppresses tumorigenesis and stimulates apoptosis in vivo

  1997cited by this paper
• Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

  1996cited by this paper
• Genetic determinants of p53-induced apoptosis and growth arrest.

  1996cited by this paper
• Life (and death) in a malignant tumour

  1996cited by this paper
• p21 is necessary for the p53-mediated G1 arrest in human cancer cells.

  1995cited by this paper
• A p53-independent Pathway for Activation of WAF1/CIP1 Expression Following Oxidative Stress *

  1995cited by this paper
• p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

  1990cited by this paper

• Peculiar Cat with Many Lives: PUMA in Viral Infections

  2026cites this paper
• TH-302 (evofosfamide) monotherapy exerts anticancer activity in Ewing's sarcoma cells under hypoxia

  2025cites this paper
• Reduced store operated calcium entry contributes to autophagy mediated escape of prostate cancer to oxaliplatin treatment.

  2025cites this paper
• BIRC5 dependency defines a targetable vulnerability in TP53 mutant acute myeloid leukemia

  2025cites this paper
• The multifaceted role of PUMA in cell death pathways: its therapeutic potential across cancer types

  2025cites this paper
• Balancing Regeneration and Resistance: Targeting DCLK1 to Mitigate Gastrointestinal Radiation Injury and Oncogenesis

  2025cites this paper
• Pandora’s Box of AML: How TP53 Mutations Defy Therapy and Hint at New Hope

  2025cites this paper
• p53-induced RNA-binding protein ZMAT3 inhibits transcription of a hexokinase to suppress mitochondrial respiration

  2025cites this paper
• Harnessing PUMA's lethal potential: BCL-2 family dynamics and novel strategies to combat cancer recurrence.

  2025cites this paper
• TP53 mutations drive therapy resistance via post-mitochondrial caspase blockade

  2025cites this paper
• Depletion of oxysterol-binding proteins by OSW-1 triggers RIP1/RIP3-independent necroptosis and sensitization to cancer immunotherapy

  2025cites this paper
• Cell Death in Crustacean Immune Defense

  2024cites this paper
• Relocalizing transcriptional kinases to activate apoptosis

  2024cites this paper
• Toxic effects of the insecticide tolfenpyrad on zebrafish embryos: Cardiac toxicity and mitochondrial damage

  2024cites this paper
• BRAF V600E-induced distinct DNA damage response defines the therapeutic potential of p53 activation for TP53 wild-type colorectal cancer.

  2024cites this paper
• Antioxidant Defenses, Oxidative Stress Responses, and Apoptosis Modulation in Spontaneous Abortion: An Immunohistochemistry Analysis of First-Trimester Chorionic Villi

  2024cites this paper
• Injectable Hydrogel Delivery System with Nintedanib and Chloroquine Triggers Apoptosis and Inhibits Protective Autophagy

  2024cites this paper
• Novel genetically engineered mouse models for clear cell renal cell carcinoma

  2023cites this paper
• The Plasma Membrane Monoamine Transporter is Highly Expressed in Neuroblastoma and Functions as an mIBG Transporter

  2023cites this paper
• Borrowing Transcriptional Kinases to Activate Apoptosis

  2023cites this paper
• PUMA/RIP3 mediates chemotherapy response via necroptosis and local immune activation in colorectal cancer.

  2023cites this paper
• New insights into the combined toxicity of aflatoxin B1 and fumonisin B1 in HepG2 cells using Seahorse respirometry analysis and RNA transcriptome sequencing.

  2023cites this paper
• Apoptosis

  2023cites this paper
• Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt’s lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib

  2023cites this paper
• Ubiquitin-proteasome pathway-mediated regulation of the Bcl-2 family: effects and therapeutic approaches

  2023cites this paper
• IFNα primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilization.

  2023cites this paper
• Downregulation of microRNA‑494 inhibits cell proliferation in lung squamous cell carcinoma via the induction of PUMA‑α‑mediated apoptosis

  2023cites this paper
• Enhanced expression of p21 promotes sensitivity of melanoma cells towards targeted therapies

  2022cites this paper
• Mangosteen Inhibits Growth and Survival of Cervical Cancer Cells

  2022cites this paper
• The SKP2‐p27 axis defines susceptibility to cell death upon CHK1 inhibition

  2022cites this paper
• Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.

  2022cites this paper
• BH3-Only Proteins Noxa and Puma Are Key Regulators of Induced Apoptosis

  2022cites this paper
• Context-dependent activation of p53 target genes and induction of apoptosis by actinomycin D in aerodigestive tract cancers

  2022cites this paper
• Genetic interactions of mitochondrial sirtuins in brain tumorigenesis.

  2022cites this paper
• Research Progress in the Regulation of Puma Expression by microRNA in Non-Neoplastic Diseases

  2022cites this paper
• Endogenous and imposed determinants of apoptotic vulnerabilities in cancer.

  2022cites this paper
• PUMA overexpression dissociates thioredoxin from ASK1 to activate the JNK/BCL-2/BCL-XL pathway augmenting apoptosis in ovarian cancer.

  2022cites this paper
• Dysregulation of cellular membrane homeostasis as a crucial modulator of cancer risk

  2022cites this paper
• The prognostic and clinical value of p53 upregulated modulator of apoptosis expression in solid tumors: a meta-analysis and TCGA data review

  2022cites this paper
• Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer

  2022cites this paper
• Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy

  2022cites this paper
• Synthetical lethality of Werner helicase and mismatch repair deficiency is mediated by p53 and PUMA in colon cancer

  2022cites this paper
• MY11 exerts antitumor effects through activation of the NF-κB/PUMA signaling pathway in breast cancer

  2022cites this paper
• The Role of miR-29s in Human Cancers—An Update

  2022cites this paper
• Functional Analysis of the Oncogene Carnitine Palmitoyltransferase 1C and Its Regulation under Hypoxia

  2021cites this paper
• Melatonin abated Bisphenol A–induced neurotoxicity via p53/PUMA/Drp-1 signaling

  2021cites this paper
• TMT-Based Quantitative Proteomic Analysis Identified Proteins and Signaling Pathways Involved in the Response to Xanthatin Treatment in Human HT-29 Colon Cancer Cells.

  2021cites this paper
• FBXL20 promotes breast cancer malignancy by inhibiting apoptosis through degradation of PUMA and BAX

  2021cites this paper
• The redox-senescence axis and its therapeutic targeting

  2021cites this paper
• Dying to Survive—The p53 Paradox

  2021cites this paper
• Using TUNEL Assay to Quantitate p53-Induced Apoptosis in Mouse Tissues.

  2021cites this paper
• 6‐Shogaol induces apoptosis in acute lymphoblastic leukaemia cells by targeting p53 signalling pathway and generation of reactive oxygen species

  2021cites this paper
• PUMA mediated afatinib-induced apoptosis in glioma cells

  2021cites this paper
• DNA damage triggers an interplay between wtp53 and c-Myc affecting lymphoma cell proliferation and KSHV replication.

  2021cites this paper
• HSP27 role in cardioprotection by modulating chemotherapeutic doxorubicin-induced cell death

  2021cites this paper
• The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer

  2021cites this paper
• A comparative assessment of in vitro cytotoxic activity and phytochemical profiling of Andrographis nallamalayana J.L.Ellis and Andrographis paniculata (Burm. f.) Nees using UPLC-QTOF-MS/MS approach

  2021cites this paper
• Expression and inhibitory effects of p53-upregulated modulator of apoptosis in gallbladder carcinoma

  2021cites this paper
• NLRP3 Inflammasome is Activated in Rat Pancreatic Islets by Transplantation and Hypoxia

  2020cites this paper
• Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal

  2020cites this paper
• The pseudo-caspase FLIP(L) regulates cell fate following p53 activation

  2020cites this paper
• NOXA-dependent contextual synthetic lethality of BCL-XL inhibition and “osmotic reprogramming” in colorectal cancer

  2020cites this paper
• MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression

  2020cites this paper
• Induction of cell cycle arrest and apoptosis by tomentosin in hepatocellular carcinoma HepG2 and Huh7 cells

  2020cites this paper
• PUMA-mediated epithelial cell apoptosis promotes Helicobacter pylori infection-mediated gastritis

  2020cites this paper
• Comparative analyses of tumorigenic mechanisms of Merkel cell polyomavirus T antigens

  2020influential citation
• Combining DNA Damage Induction with BCL-2 Inhibition to Enhance Merkel Cell Carcinoma Cytotoxicity

  2020cites this paper
• RETRACTED ARTICLE: Inhibition of EZH2 enhances the therapeutic effect of 5-FU via PUMA upregulation in colorectal cancer

  2020cites this paper
• The long non-coding RNA TSLC8 inhibits colorectal cancer by stabilizing puma

  2020cites this paper
• Dihydronicotinamide riboside promotes cell-specific cytotoxicity by tipping the balance between metabolic regulation and oxidative stress

  2020cites this paper
• Pioglitazone alleviates cisplatin nephrotoxicity by suppressing mitochondria‐mediated apoptosis via SIRT1/p53 signalling

  2020cites this paper
• eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis

  2020cites this paper
• RETRACTED ARTICLE: Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer

  2020cites this paper
• A novel Bcl-2 inhibitor, BM-1197, induces apoptosis in malignant lymphoma cells through the endogenous apoptotic pathway

  2019cites this paper
• Encorafenib inhibits migration, induces cell cycle arrest and apoptosis in colorectal cancer cells

  2019cites this paper
• The multiple mechanisms that regulate p53 activity and cell fate

  2019cites this paper
• The better effects of microbubble ultrasound transfection of miR-940 on cell proliferation inhibition and apoptosis promotion in human cervical cancer cells

  2019cites this paper
• Mutant p53 drives cancer chemotherapy resistance due to loss of function on activating transcription of PUMA

  2019cites this paper
• Modeling the regulation of p53 activation by HIF‐1 upon hypoxia

  2019cites this paper
• The Natural Compound Neobractatin Induces Cell Cycle Arrest by Regulating E2F1 and Gadd45α

  2019cites this paper
• Targeting mTOR suppressed colon cancer growth through 4EBP1/eIF4E/PUMA pathway

  2019cites this paper
• Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer

  2019cites this paper
• Combined inhibition of MDM2 and BCR-ABL1 tyrosine kinase targets chronic myeloid leukemia stem/progenitor cells in a murine model

  2019cites this paper
• The molecular mechanisms associated with PIN7, a protein-protein interaction network of seven pleiotropic proteins.

  2019cites this paper
• Radiation induces apoptosis primarily through the intrinsic pathway in mammalian cells.

  2019cites this paper
• p53 Up‐regulated Modulator of Apoptosis Induction Mediates Acetaminophen‐Induced Necrosis and Liver Injury in Mice

  2019cites this paper
• Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity

  2019cites this paper
• Hsp27 reduces cold ischemia-reperfusion injury in heart transplantation through regulation of NF-κB and PUMA signaling.

  2018cites this paper
• Venetoclax: A new wave in hematooncology.

  2018cites this paper
• A Systematic Review of miR-29 in Cancer

  2018cites this paper
• Inhibition of Casein Kinase 2 Protects Oligodendrocytes From Excitotoxicity by Attenuating JNK/p53 Signaling Cascade

  2018cites this paper
• Neuronal Cell Death.

  2018cites this paper
• RETRACTED ARTICLE: MEK inhibitors induce apoptosis via FoxO3a-dependent PUMA induction in colorectal cancer cells

  2018cites this paper
• Follistatin‐like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase‐dependent apoptosis and regulating Bcl‐2 family proteins

  2018cites this paper
• Hypoxia-inducible factor HIF-1 α modulates drugs resistance in colon cancer cells Factor inducible por hipoxia HIF-1 α modula

  2018cites this paper
• Downregulation of MCL-1 and upregulation of PUMA using mTOR inhibitors enhance antitumor efficacy of BH3 mimetics in triple-negative breast cancer

  2018cites this paper
• Dietary Red Raspberry Reduces Colorectal Inflammation and Carcinogenic Risk in Mice with Dextran Sulfate Sodium–Induced Colitis

  2018cites this paper
• Lysine-specific demethylase 2A expression is associated with cell growth and cyclin D1 expression in colorectal adenocarcinoma

  2018cites this paper
• Mcl-1 Phosphorylation without Degradation Mediates Sensitivity to HDAC Inhibitors by Liberating BH3-Only Proteins.

  2018cites this paper
• Targeting p53-dependent stem cell loss for intestinal chemoprotection

  2018cites this paper